LLY

749.48

-0.89%↓

JNJ

176.96

-0.68%↓

ABBV

217.85

-0.57%↓

UNH

348.05

-0.48%↓

AZN

77.88

-0.5%↓

LLY

749.48

-0.89%↓

JNJ

176.96

-0.68%↓

ABBV

217.85

-0.57%↓

UNH

348.05

-0.48%↓

AZN

77.88

-0.5%↓

LLY

749.48

-0.89%↓

JNJ

176.96

-0.68%↓

ABBV

217.85

-0.57%↓

UNH

348.05

-0.48%↓

AZN

77.88

-0.5%↓

LLY

749.48

-0.89%↓

JNJ

176.96

-0.68%↓

ABBV

217.85

-0.57%↓

UNH

348.05

-0.48%↓

AZN

77.88

-0.5%↓

LLY

749.48

-0.89%↓

JNJ

176.96

-0.68%↓

ABBV

217.85

-0.57%↓

UNH

348.05

-0.48%↓

AZN

77.88

-0.5%↓

Search

Inmode Ltd

Suletud

SektorTervishoid

14.68 -0.88

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

14.71

Max

14.94

Põhinäitajad

By Trading Economics

Sissetulek

8.5M

27M

Müük

18M

96M

P/E

Sektori keskmine

6.42

35.664

Aktsiakasum

0.31

Kasumimarginaal

27.972

Töötajad

599

EBITDA

15M

31M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+18% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

29. okt 2025

Turustatistika

By TradingEconomics

Turukapital

35M

966M

Eelmine avamishind

15.56

Eelmine sulgemishind

14.68

Uudiste sentiment

By Acuity

50%

50%

183 / 371 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

Inmode Ltd Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

15. sept 2025, 22:39 UTC

Omandamised, ülevõtmised, äriostud

CSL Agrees to Deal to Advance Coagulation Treatment, May Acquire Developer

15. sept 2025, 16:43 UTC

Suurimad hinnamuutused turgudel

Strive Shares Sink on Board Disclosure; Bitcoin Treasury Strategy

15. sept 2025, 16:42 UTC

Suurimad hinnamuutused turgudel

Helius Medical Tech Jumps on Funding to Launch Solana Treasury

15. sept 2025, 16:35 UTC

Suurimad hinnamuutused turgudel

Chegg to Pay $7.5 Million to Settle FTC Claims Over Subscription Cancellation Process

15. sept 2025, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15. sept 2025, 23:46 UTC

Market Talk

Nikkei May Rise as Fed Rate Cut Hopes Support Stocks -- Market Talk

15. sept 2025, 23:34 UTC

Market Talk

Gold Steady Ahead of FOMC Meeting, Major U.S. Economic Data -- Market Talk

15. sept 2025, 22:48 UTC

Market Talk

FOMC May Opt to Play Catch Up With Rate Cuts -- Market Talk

15. sept 2025, 22:12 UTC

Omandamised, ülevõtmised, äriostud

CSL Expects Commercial Launch in 2029

15. sept 2025, 22:12 UTC

Omandamised, ülevõtmised, äriostud

CSL Says VarmX to Receive Further Commercial Milestones Afterwards

15. sept 2025, 22:11 UTC

Omandamised, ülevõtmised, äriostud

CSL Says VarmX to Receive Payments of Up to $388 Million Up to Launch of VMX-C001

15. sept 2025, 22:11 UTC

Omandamised, ülevõtmised, äriostud

CSL to Have Right to Exercise Option Based on Phase 3 Data

15. sept 2025, 22:10 UTC

Omandamised, ülevõtmised, äriostud

CSL to Make Upfront Payment to VarmX of $117 Million for Exclusive Option to Acquire Company

15. sept 2025, 21:16 UTC

Omandamised, ülevõtmised, äriostud

Chord Energy: Assets Have a Low Avg NYMEX WTI Breakeven and Are Immediately Competitive for Capital

15. sept 2025, 21:16 UTC

Omandamised, ülevõtmised, äriostud

Chord Energy: Assets Have Significant Overlap With Existing Footprint, Setting the Stage for Long-Lateral Development

15. sept 2025, 21:15 UTC

Omandamised, ülevõtmised, äriostud

Chord Energy to Buy 48,000 Net Acres in the Williston Core

15. sept 2025, 21:14 UTC

Omandamised, ülevõtmised, äriostud

Chord Energy to Buy Assets in Williston Basin From Exxon's XTO Energy and Affiliates for $550M

15. sept 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15. sept 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

15. sept 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

15. sept 2025, 19:29 UTC

Market Talk

U.S. Natural Gas Gains on Warmer Weather Outlook -- Market Talk

15. sept 2025, 19:14 UTC

Market Talk

Attacks on Russia Lifts Oil Price Despite Shaky Fundamentals -- Market Talk

15. sept 2025, 18:16 UTC

Market Talk

Gold Powers to New High -- Market Talk

15. sept 2025, 18:05 UTC

Market Talk

Easing Autonomous Vehicle Regulations Will Begin Tesla's Next Chapter -- Market Talk

15. sept 2025, 17:50 UTC

Omandamised, ülevõtmised, äriostud

U.S. Reaches Outline of Deal With China Over TikTok -- 2nd Update

15. sept 2025, 17:10 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15. sept 2025, 17:10 UTC

Market Talk

S&P Expects Fed, BOC to Cut Rates -- Market Talk

15. sept 2025, 16:52 UTC

Market Talk

Copper Climbs as Traders Brace for U.S. Rate Cut -- Market Talk

15. sept 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

15. sept 2025, 16:20 UTC

Market Talk
Tulu

Auto & Transport Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

Inmode Ltd Prognoos

Hinnasiht

By TipRanks

18% tõus

12 kuu keskmine prognoos

Keskmine 17.5 USD  18%

Kõrge 21 USD

Madal 14 USD

Põhineb 4 Wall Streeti analüütiku instrumendi Inmode Ltd 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

4 ratings

1

Osta

3

Hoia

0

Müü

Tehniline skoor

By Trading Central

14.1 / 14.44Toetus ja vastupanu

Lühikene perspektiiv

Bearish Evidence

Keskpikk perspektiiv

Strong Bearish Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

183 / 371 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Keskmine

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Inmode Ltd

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.
help-icon Live chat